ArticleProceedings of the National Academy of Sciences of the United States of America2025

Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.

Alexandra C Bayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.